Radiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines
- PMID: 27841119
- PMCID: PMC4873915
- DOI: 10.1017/S0022215116000463
Radiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. Radiotherapy is one of the key treatment modalities used in head and neck cancer management. This paper summarises the current role and some of the recent advances in radiotherapy in head and neck cancer management.
References
-
- Denaro N, Russi EG, Lefebvre JL, Merlano MC. A systematic review of current and emerging approaches in the field of larynx preservation. Radiother Oncol 2014;110:16–24 - PubMed
-
- Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873–9 - PubMed
-
- Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7–16 - PubMed
-
- Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical